Chronic pain following surgery, persistent postsurgical pain, is an important condition contributing to significant symptom burden and lower quality of life1. Persistent post-surgical pain remains poorly understood, but is broadly recognized as pain lasting more than 3 months after surgery2. The condition is common, with estimates of its prevalence ranging from 10% to 50% of all postsurgical patients3. High-risk procedures include breast surgery4, thoracotomy5, limb amputation6, and hernia repair7. Persistent postsurgical pain is relatively refractory to treatment and thus has generated interest in potential preventive strategies and treatments. A better understanding of predicting and characterizing persistent postoperative pain would help identify the subset of patients who are likely to require additional treatment to optimize their peri-operative pain management.
Recently it was shown that abnormal changes in pain thresholds in response to surgery may be of predictive value for long-term persistent pain development in the context of surgery for breast cancer8. Others have stressed the importance of the conditioned pain modulation (CPM) effect in predicting persistent postoperative pain, for example with regards to persistent pain after thoracotomy5. CPM is the behavioral correlate of diffuse noxious inhibitory control, a physiological phenomenon where input from peripheral c-fibers results in diffuse inhibition from the brainstem of all incoming stimuli mediated by c-fiber from heterotopic fields9. The CPM effect is measured by comparing thresholds to a noxious stimulus, which is measured before and after the application of a second different stimulus, which is referred to as the conditioning stimulus10.
Current standardized quantitative sensory testing (QST) protocols, such as the German Research Network on Neuropathic Pain protocol11 are quite extensive and may not be suitable to perform in surgical patients. The aim of the current publication is to detail a short and standardized protocol to obtain both pain thresholds and a CPM effect measurement in breast cancer surgery patients. This protocol is derived from a collaborative protocol between our university and the University of Aalborg, Denmark12.